{"cluster": 38, "subcluster": 4, "abstract_summ": "Considering the high transmission rate of the virus and limitations in resources such as intensive care unit (ICU) beds and blood products, in many countries living donor transplantations and pancreas transplantation have been delayed to after the diseases has subsided.The first case of COVID-19 in Portugal was notified in March 02, 2020.The effect of coronavirus disease 2019 (COVID-19) on liver transplantation programmes and recipients is still not completely understood but overall involves the risk of donor-derived transmission, the reliability of diagnostic tests, health-care resource utilization and the effect of immunosuppression.This Comment reviews the effect of COVID-19 on liver transplantation and summarizes recommendations for donor and recipient management.Following the December 2019 SARS-CoV-2 outbreak in China, France is now fifth in number of deaths worldwide while at the same time hosting one of the biggest European liver transplantation programs.We read with interest the analysis on modern approaches to organ transplantation during the COVID-19 pandemic by Kumar et al.1 .", "title_summ": "Liver transplantation in an ICU dominated by COVID-19.COVID-19 and liver transplantationCOVID\u201019: Thoughts and comments from a tertiary liver transplant center in FranceCOVID\u201019 Infection in Early Post\u2010Operative Period after Liver TransplantationIntestinal transplantation during COVID-19 pandemic.", "title_abstract_phrases": "Considering the high transmission rate of the virus and limitations in resources such as intensive care unit (ICU) beds and blood products, in many countries living donor transplantations and pancreas transplantation have been delayed to after the diseases has subsided.The first case of COVID-19 in Portugal was notified in March 02, 2020.COVID-19 and liver transplantationThe effect of coronavirus disease 2019 (COVID-19) on liver transplantation programmes and recipients is still not completely understood but overall involves the risk of donor-derived transmission, the reliability of diagnostic tests, health-care resource utilization and the effect of immunosuppression.COVID\u201019: Thoughts and comments from a tertiary liver transplant center in FranceWe read with interest the analysis on modern approaches to organ transplantation during the COVID-19 pandemic by Kumar et al.1 .This Comment reviews the effect of COVID-19 on liver transplantation and summarizes recommendations for donor and recipient management.Following the December 2019 SARS-CoV-2 outbreak in China, France is now fifth in number of deaths worldwide while at the same time hosting one of the biggest European liver transplantation programs."}